Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2023 | Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis | Silverberg, Jonathan I; Guttman-Yassky, Emma; Thaçi, Diamant; Irvine, Alan D; Stein Gold, Linda; Blauvelt, Andrew; Simpson, Eric L; CHIA-YU CHU ; et al., | The New England journal of medicine | 46 | 22 |